Amy Burroughs

Amy Burroughs is a highly accomplished professional with a diverse background in business, economics, and computer science.

She holds a Bachelor of Arts in Economics and Computer Science from Dartmouth College and a Master of Business Administration from Harvard Business School.

Amy has held key leadership positions including President and Chief Executive Officer at Cleave Therapeutics, Senior Advisor at Crinetics Pharmaceuticals, and Executive In Residence at 5Am Ventures.

Her extensive experience also includes roles such as Strategic Partner at Dna Ink, Consultant at Egon Zehnder, and Managing Partner at The Ventral Group.

Amy was previously the Chief Commercial Officer and Head of Business Development at Apt Pharmaceuticals and Commercial Team Leader at Genentech.

She has further enriched her career with positions like Director at Ephysician Inc and American Whole Health, as well as serving as the Charles Williams Fellow at Harvard University.

Amy Burroughs has also gained valuable insights through her roles as a Summer Consultant at The Boston Consulting Group (Bcg), Assistant Brand Manager at Procter & Gamble, and Co-Op Student at Central Intelligence Agency.